PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16038077

Genetic testing: for whose benefit is it provided?

M L Begleiter
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

CommerceEugenicsGenetic PrivacyGenetic TestingGenetics, MedicalHealth PersonnelHumansIndustryNeural Tube DefectsGenetics and ReproductionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M L Begleiter. 1992. Genetic testing: for whose benefit is it provided?. https://pubmed.ncbi.nlm.nih.gov/16038077/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Impact of the FTSE4Good Index on firm price: an event study.

This paper examines whether corporate financial performance is affected by public endorsement of environmental and social performance. Event study methodology, which relies on the notion of market efficiency, is used to examine the relationship between positive and negative announcements and changes in share prices or daily returns. Inclusion in and deletion from the FTSE4Good UK Index is used as a proxy measure for good (poor) corporate social responsibility. The abnormal or unexpected daily returns associated with an event are calculated and their significance tested. The results show a trend towards positive and negative announcements having the expected effects on daily returns. But these movements are not significant and the data do not suggest that a firm's presence on the index brings it any significant financial return for signalling its corporate social responsibility.

Commerce↗